Interim results for the six months ended June 30, 2026
September 11, 2026Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”)Interim results for the six months ended June 30, 2026Biodexa Pharmaceuticals PLC NASDAQ:BDRX, a clinical-stage biopharmaceutical company developing innovative products focused on the treatment or prevention of gastrointestina…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.